Member Info for scotlouie

Top 20 Shareholders as of 9 January 2013 RANK NAME UNITS % 1 COMPUTERSHARE CLEARING PTY LTD <CCNL DI A/C> 89,969,585 58.66% 2 HSBC CUSTODY NOMINEES (AUSTRALIA) LIMITED 12,983,655 8.47% 3 JP MORGAN NOMINEES AUSTRALIA LIMITED <CASH INCOME A/C> 8,822,455 5.75% 4 VITORIA PTY LTD 2,377,779 1.55% 5 CITICORP NOMINEES PTY LTD 1,662,854 1.08% 6 GLENNBROWN PTY LTD <G BROWN FAMILY ACCOUNT> 1,333,334 0.87% 7 J P MORGAN NOMINEES AUSTRALIA LIMITED 1,005,885 0.66% 8 RACOVALIS SUPERANNUATION FUND PTY LTD <RACO SUPER FUND A/C> 970,000 0.63% 9 MR ERKIN SVANBAYEV 900,001 0.59% 10 MR GEOFFREY ANTHONY GANDER <THE GANDER SUPER A/C> 625,000 0.41% 11 MR ATHOL GEOFFREY JAMES 608,148 0.40% 12 MR STEPHEN JOHN KINMOND 490,714 0.32% 13 GJ MARANO SUPER PTY LTD 473,011 0.31% 14 DEVANA CORPORATION PTY LTD <HAYWARD SUPER FUND 2 A/C> 435,846 0.28% 15 PALS INVESTMENTS PTY LTD 385,000 0.25% 16 GAINSPELL PTY LTD 333,334 0.22% 17 ASCENT CAPITAL HOLDINGS PTY LT 308,334 0.20% 18 SILVERLIGHT HOLDINGS PTY LTD <CAIRNS INVESTMENT A/C> 306,450 0.20% 19 MR DAMIAN RONALD GILLMAN + MRS LUCIA GILLMAN <DAMIAN & LUCIA GILLMAN A/C> 291,667 0.19% 20 MR WARREN GILMOUR + MRS CATHERINE GILMOUR <W + C GILMOUR SUPER A/C> 282,753 0.18% Total 124,565,805 81.22% http://www.jupiterenergy.com.au/Investor-Centre/Top-20-Shareholders

Issued Share Capital Lombard Medical's issued share capital consists of 20,161,812 ordinary shares with a nominal value of 20 pence each, with voting rights. Lombard Medical does not hold any ordinary shares in Treasury. Shares Not In Public Hands The Directors hold 590,181 ordinary shares. Shareholders holding over 10% each: Invesco Ltd and Abingworth LLP hold a total of 10,433,038 ordinary shares and therefore the total of shares "not in public hands" amounts to 11,023,219 shares, 54.7% of those in issue. Last Updated: 04 April 2012 Significant Shareholders No. of shares % of issued shares Invesco Ltd 7,918,753 39.3% Abingworth 2,514,285 12.5% MVM 1,571,428 7.8% Fidelity International Ltd 1,141,440 5.7% evYsio Medical Devices LLC 1,062,857 5.3% VERY LITTLE SHARES LEFT http://www.lombardmedical.com/pwpcontrol.php?pwpID=5257

London, UK, 15 February 2013- Lombard Medical Technologies PLC (AIM: LMT), the specialist medical technology company focused on innovative vascular products, today announces that Aorfix?has been approved for commercial sale in the U.S. by the U.S. Food and Drug Administration ("FDA"). Aorfix?is the Company's flexible stent graft for the endovascular repair of abdominal aortic aneurysms ("AAAs"). Data from the U.S. PYTHAGORAS trial of Aorfix?, has demonstrated that Aorfix? can successfully treat a larger patient population than competing devices, including both standard and difficult to treat cases of AAAs. The U.S. approval for Aorfix? includes a label indication for the treatment of patients with angulations at the neck of the aneurysm from 0 to 90 degrees. Aorfix? is now the only endovascular stent graft licensed in the U.S. for use in more challenging cases with neck angulations greater than 60 degrees. Independent market research suggests that the U.S. market for the repair of AAAs is worth over $600 million per annum1, is forecast to grow at approximately 8%1 per annum, and that up to 30% of all patients have some tortuosity either at the neck of the aneurysm or in the iliac arteries2. It is to this segment of patients that Aorfix? is targeted with its uniquely flexible design. In Europe Aorfix? is already licensed to treat neck angulations of up to 90 degrees. The PYTHAGORAS trial of Aorfix? is the largest prospective controlled study, to date, of stent grafting in patients with highly angled aortas. 218 patients at risk of aneurysm rupture were recruited in the trial and included 151 patients with neck angles greater than 60 degrees and 67 patients with neck angles less than 60 degrees. No aneurysms expanded in patients with neck angles less than 60 degrees and just 1.8% expanded in the patients with high neck angles, comparing favourably with the results of other devices in normal, less tortuous anatomy. The approval of Aorfix?triggers receipt of the c. £14.1m Second Tranche of the two tranche placing and subscription announced by the Company on 20 April 2011 (the "May 2011 Fundraising"). Funds from the Second Tranche will be used to launch AorfixTM in the U.S. through the Company's own direct sales force. In addition to building the U.S. sales and marketing infrastructure, funds from the Second Tranche will also be used to expand production capacity to meet anticipated demand for the AorfixTM stent graft, complete the planned extension of stent graft sizes and develop the next generation, lower profile delivery device. Funds from the Second Tranche will also be used to redeem the full amount of the £3m Convertible Loan Notes issued to Invesco Asset Management Limited ("Invesco") to the extent that Invesco has not already converted, or indicated its willingness to convert, the Convertible Loan Notes. Additional funding will subsequently be sought to allow the Company to ac

U.S. approval of Aorfix?also triggers the Company's ability to draw down $2.5m from the $5.0m loan facility granted by its exclusive distribution partner in Japan, Medico's Hirata Inc. Medico's Hirata is a leading supplier and developer of medical device products in Japan, with the sales infrastructure to maximise the potential of Aorfix? in this important market. Lombard Medical continues to work with its partner to achieve Aorfix?approval in Japan, which it anticipates will be in 2014. In May 2012 the Company announced a strategic partnership with Machine Solutions Inc. (MSI), a global supplier of process and testing solutions for the medical device industry. This partnership formed part of the Company's wider plan to develop improved manufacturing processes and efficiencies for Aorfix?. In utilising technology developed in collaboration with Machine Solutions, the Company is confident of meeting product demand and capacity requirements following the launch of Aorfix?in the U.S. CEO of Lombard Medical Technologies, Simon Hubbert, commented: "FDA approval of Aorfix? is a major milestone for the Company and sets the stage for the next chapter in the Company's growth. I would like to thank all of our employees, investigators and clinical advisors for their support and hard work, without which development and approval of Aorfix? would not have been possible. Aorfix? is now the only stent graft approved in the U.S. to treat AAAs with neck angulations up to 90 degrees, a key advantage over other currently available stent grafts. We look forward to launching Aorfix? in the U.S. through our own sales force and are confident of securing a meaningful share of this growing market." Dr Mark Fillinger of Dartmouth Hitchcock Medical Centre, New Hampshire (principal investigator for the Aorfix?trial), commented: "Having seen the benefits of using Aorfix? in patients first hand, I am delighted such a device is now available to treat patients in the U.S. Aorfix? allows a minimally invasive repair of complicated high-angle AAAs to be performed, addressing a clear unmet medical need. These patients would otherwise require relatively high risk and more expensive open heart surgery and many are not strong enough to undergo such a serious intervention."

ive not seen the link on here so here it is http://www.4-traders.com/LOMBARD-MEDICAL-TECHNOLOG-4005711/news/Lombard-Medical-Technologies-PLC-US-FDA-Approval-of-Aorfix-16052359/

where can you see it going?

Going to sell the company? I'm trying to figure out why he is trying to rack up stocks... Almost to 75% of the whole company? What he planning??

What's going on here dude? Why the rise? Any RNS released? SP looked good at .043 now lol!! Don't know of it will just fall back tomorrow of if it's something behind the sceens which is causing the rise

Ah right I picked up the last RNS wrong, I thought it was march 2013... Was looking at today's SP for a good entry as might bounce from these levels buy if your right and sale isn't until next year then got a feeling it could be drifting down even more unless good news is out... Great oppertunity to make a good return if your timing is right, depending what the SP is when the sale goes thro then could have a 200-300% increase on SP, possibly over night and be rerated!! Saying that I don't want to jump in where I can increase my holding somewhere else and jump back here.. I'll be watching closely with this well under the radar one ;)

And others, can you see the sale coming through by the first quarter?

According to morningstar the major holders are: Owners is a feature of Morningstar Premium. To learn more, click here Major Shareholders Shareholder Type Amount % Holding Stephen Koo (dup) - 277,703,700 72.38 UniVision Holdings Ltd (dup) - 183,736,000 47.89 Up sky Investments Ltd (dup) - 78,744,000 20.52 Barclayshare Nominees Ltd - 21,354,634 5.57 WB Nominees Ltd - 20,231,800 5.27 Director Holdings But obv this isn't right, as too many shares/percentage, does anyone know the real figures?

hey guys... stumbled on this little share which is under the radar, by a quick glance at the post people mention about 2015 will be the pay year... its similar to my other holding in ORE... and i think i may need to do a little bit of research on this stock ;) ... i could jump in after that!

Amino Technologies Expects FY Profit Ii Line With Board's View - Quick Facts 12/4/2012 2:47 AM ET Amino Technologeis Plc (AMO.L) Tuesday released the trading update for the year ended 30 November 2012, stating that the company expects to deliver a profit for the year in line with market expectations as a result of the Board's ongoing focus on operational performance and continued success in delivering gross margin improvements. The Cambridge-based leader in digital entertainment solutions for IPTV, OTT ans in-home multimedia distribution further stated that total Revenues for the year are expected to be approximately 41 million pounds as management continued to focus on executing only high margin, cash generative business. The Company further stated that the Board is pleased to be recommending a full year dividend of 3p for the year ended 30 November 2012, a 50 per cent increase year on year, with an expectation to provide both an interim and full year dividend moving forward. http://www.rttnews.com/2016726/amino-technologies-expects-fy-profit-ii-line-with-board-s-view-quick-facts.aspx?type=qf&utm_source=google&utm_campaign=sitemap

Let's not forget that the results are due on thurs at 8am. When people see the good news then they will realise the potential here!! Let's hope it's great news on thurs and get the sp moving, as I feel the sp has been moving in the wrong direction past weeks!! When we get good news put then it will push this hare where it's meant to be and that's over 140/150 hopefully ;)

hi guys, ive just came across this share and doing a bit of background research on the company before i dip my toe in here... just a quick glance at the shares in issue and with the BOD having high numbers of shares... how many shares are there left (roughly?) and how is the cash balance doing? the company in debt? anyone knowing thise pass me the info please

thanks for the link kenny! just need to wait till next thurs for results!!!

i was thinking the MM was trying manipulate the price, as i said in the previous post if there was a leak then it would be more of a downwards spiral with the SP. ok the SP has went down this week without any news or any reason why this is the case. I dont acutally know why... just guessing. if the presentation is out tomorrow and it brings good news then i believe the SP will jump back up to where the dip happened and test the new resistance levels. ..... hmm hopefully tomorrow will clear things up

lets hope it isnt bad news.... it does look like a few people might of heard something (possibly bad news).... all i can hope for is a big surge of buys within the last half hr of trading which would a positive day tomorrow.. if the presentation is out tomorrow guess i will just need to wait and see what news it brings to BRDG... i agree with you that we have oil so thats why i was confused why it fell to 10% today... there was some small buys later on but still down 8%... the only good way is its still not dropping... if there was a leak then possibility would be more sells right up to close. maybe people are selling before the news comes out... who knows! tomorrow will be interesting

all i see if a sea of red... ive tried for a dummy sell and its not processing. i can sell 100 shares but when i try for 200+ its not going through. debating if i should bite the bullet and sell or just hang on.... any idea why its dropped 10% today?

not much chat on this BB with this stock. i know its still early days been looking through their websites and it looks like it has a bright future ahead. thinking of buying in at these levels. whats people views on this stock?